Tag: Digital Therapeutics
-
Aesyra Shows Notable Reduction in Sleep Bruxism in New Clinical Study
Introduction: A Milestone for Digital Therapeutics in Sleep Dentistry In a significant step for dental health technology, Aesyra SA, a Swiss medtech innovator, today announced the successful completion of a clinical investigation evaluating the efficacy of its digital therapeutics solution designed to reduce sleep bruxism. The study, conducted in Lausanne, Switzerland, highlights the potential of…
-
Aesyra Demonstrates Significant Sleep Bruxism Reduction in Clinical Study
Overview: A Step Forward in Treating Sleep Bruxism Aesyra SA, a Swiss medtech innovator, has announced the successful completion of a clinical investigation evaluating the efficacy of its digital therapeutic solution for sleep bruxism. The study, conducted in collaboration with clinical partners in Switzerland, demonstrates a significant reduction in bruxism events and associated symptoms among…
-
Aesyra Demonstrates Sleep Bruxism Reduction in Study
About the Clinical Investigation Aesyra SA, a Swiss medtech company focused on digital therapeutics for dental and sleep-related disorders, today announced the successful completion of a clinical investigation evaluating the efficacy of its digital intervention for sleep bruxism. Conducted at multiple sites with participants experiencing routine bruxism symptoms, the study was designed to assess reductions…
-
Applying Behavioral Science to Digital Therapeutics for Prediabetes: A Scoping Review
Introduction Prediabetes is a metabolic state where blood glucose levels are elevated above normal but do not meet the diagnostic thresholds for type 2 diabetes. The American Diabetes Association and other clinical guidelines emphasize early lifestyle intervention to prevent progression to diabetes and to reduce cardiometabolic risk. In recent years, digital therapeutics (DTx) have emerged…
-
Application of Behavioral Science in Digital Therapeutics for Prediabetes: A Scoping Review
Background: Prediabetes, Digital Therapeutics, and the Behavioral Lens Prediabetes is a transitional metabolic state characterized by elevated blood glucose levels that fall short of diabetes criteria. Without targeted intervention, many individuals with prediabetes progress to type 2 diabetes and related complications. Digital therapeutics (DTx) offer software-based interventions—often powered by mobile apps, wearables, and telehealth—that support…
-
Behavioral Science in Digital Therapeutics for Prediabetes: A Scoping Review
Background: Prediabetes and the Promise of Digital Therapeutics Prediabetes is a metabolic state where blood glucose levels are elevated above normal but do not meet diabetes criteria. Lifestyle modification and weight management are key to reducing progression risk. Digital therapeutics (DTx)—software-driven interventions delivered via mobile apps, web platforms, or connected devices—offer scalable, personalized support to…